We identified c-Myc as the upstream regulator increasing the dependency of platinum resistant ovarian cancer cell lines on glutamine metabolism via the TCA cycle and in the regulation of oxidative phosphorylation. The gene discussed is MYC; the disease is ovarian cancer.